Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · IEX Real-Time Price · USD
2.120
-0.050 (-2.30%)
Mar 18, 2024, 4:00 PM EDT - Market closed

Aadi Bioscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Net Income
-65.77-60.51-110.74-4.47-23.27-10.4-22.34-20.91-0.03
Depreciation & Amortization
0.630.540.280.180.080.050.050.070
Share-Based Compensation
11.959.642.110.141.093.430.650.490
Other Operating Activities
-6.480.6985.29-9.54-1.741.111.820.710.01
Operating Cash Flow
-59.66-49.64-22.42-12.7-23.85-5.81-18.88-15.72-0.02
Capital Expenditures
-3.97-0.44-0.050-0.24-0.04-0.01-0.110
Acquisitions
0025.2000000
Change in Investments
87.18-132.4400000.0500
Investing Cash Flow
83.21-132.8925.150-0.24-0.040.04-0.110
Dividends Paid
00-4.41000000
Share Issuance / Repurchase
0.4973.28155.830048.237.20.020
Debt Issued / Paid
0001.19000.312.280.04
Other Financing Activities
-0.16-0.66-9.62------
Financing Cash Flow
0.3372.62141.81.19048.237.512.30.04
Net Cash Flow
23.87-109.91144.53-11.51-24.0942.3518.65-3.530.01
Free Cash Flow
-63.64-50.08-22.47-12.7-24.09-5.85-18.89-15.83-0.02
Free Cash Flow Margin
-261.29%-329.15%-2006.16%-87.11%--29.00%---
Free Cash Flow Per Share
-2.36-2.23-2.52-5.00-8.90-2.58-13.07-278.50-0.07
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).